1.天津市儿童医院/天津大学儿童医院/天津市儿童出生缺陷防治重点实验室,内分泌科,天津 300134
2.天津市儿童医院/天津大学儿童医院/天津市儿童出生缺陷防治重点实验室,呼吸科,天津 300134
符榕,女,1982—,医学硕士,副主任医师,主要从事小儿内分泌方面的研究,E‑mail:furong821017@126.com
吕玲,女,1964—,医学硕士,主任医师,主要从事小儿内分泌方面的研究,E‑mail:furong82@126.com
收稿:2024-03-07,
纸质出版:2025-09-26
移动端阅览
符榕,张明英,陈枞等.不同体质量指数中枢性性早熟女童黄体生成素基础值和子宫体积检测的诊断价值[J].武汉大学学报(医学版),2025,46(09):1168-1173.
FU Rong,ZHANG Mingying,CHEN Cong,et al.Diagnosis value of luteinizing hormone base value and uterine volume in central precocious puberty girls with different BMI[J].Medical Journal of Wuhan University,2025,46(09):1168-1173.
符榕,张明英,陈枞等.不同体质量指数中枢性性早熟女童黄体生成素基础值和子宫体积检测的诊断价值[J].武汉大学学报(医学版),2025,46(09):1168-1173. DOI: 10.14188/j.1671-8852.2024.0154.
FU Rong,ZHANG Mingying,CHEN Cong,et al.Diagnosis value of luteinizing hormone base value and uterine volume in central precocious puberty girls with different BMI[J].Medical Journal of Wuhan University,2025,46(09):1168-1173. DOI: 10.14188/j.1671-8852.2024.0154.
目的
2
探究不同体质量指数(BMI)中枢性性早熟女童黄体生成素基础值和子宫体积检测价值。
方法
2
回顾性分析2019年1月至2023年8月在天津市儿童医院儿科门诊以第二性征提前发育为主诉的女童共488例,其中BMI正常范围女童368例,BMI升高女童120例,对其进行促性腺激素释放试验,并测定相关实验室指标及子宫体积,应用SPSS 21.0软件对数据进行统计分析。
结果
2
BMI正常范围促性腺激素释放试验阳性组172例,促性腺激素释放试验阴性组196例;BMI升高组,阳性组58例、阴性组62例。两组女童阳性组黄体生成素基础值联合子宫体积均大于阴性组,BMI正常范围、BMI升高黄体生成素基础值诊断中枢性性早熟的界值分别为0.428、0.325 IU•L
-1
,子宫体积的界值分别为2.729、2.424 mL,敏感度分别能达到61.2%、57.4%,特异度分别能达到89.7%、84.2%;不同BMI下应用黄体生成素基础值联合子宫体积诊断中枢性性早熟的诊断曲线下面积高于单用子宫体积诊断,差异具有统计学意义(
P
<
0.001),但不同BMI下应用黄体生成素基础值联合子宫体积诊断中枢性性早熟与黄体生成素基础值诊断的曲线下面积比较差异无统计学意义(
P
>
0.05)。
结论
2
联合测定黄体生成素基础值与子宫体积对不同BMI女童中枢性性早熟的临床诊断均具有可靠的价值,能够作为一种简便易行的方式用以中枢性性早熟的诊断。
Objective
2
To investigate the diagnostic value of luteinizing hormone (LH) base value and uterine volume in girls with central precocious puberty with different body mass index (BMI).
Methods
2
A total of 488 girls who complained of early development of secondary sex characteristics in the pediatric clinic of Tianjin Children's Hospital from January 2019 to August 2023 were retrospectively analyzed
including 368 girls within the normal BMI range and 120 girls with above⁃normal BMI. Gonadotropin release test was performed on them
and relevant laboratory indicators and uterine volume were determined. SPSS 21.0 software was used for statistical analysis of the data.
Results
2
Among them
172 cases were positive group and 196 cases were negative group. BMI was increased in 58 cases in positive group and 62 cases in negative group. Luteinizing hormone base value combined with uterine volume in the positive group was greater than that in the negative group. The threshold values of normal BMI range and elevated BMI luteinizing hormone base value in the diagnosis of central precocious puberty were 0.428 IU•L
-1
and 0.325 IU•L
-1
respectively
and the threshold values of uterine volume were 2.729 mL and 2.424 mL
respectively. The sensitivity was 61.2% and 57.4%
and the specificity was 89.7% and 84.2%
respectively. The area under the diagnosis curve(
AUC
) of central precocious puberty using luteinizing hormone base value combined with uterine volume under different BMI was higher than that using uterine volume alone
and the results were statistically different (
P
<
0.001)
but there was no significant difference in
AUC
between luteinizing hormone base value combined with uterine volume and luteinizing hormone base value in the diagnosis of central precocious puberty (
P
>
0.05).
Conclusion
2
The combination of luteinizing hormone base value and uterine volume of girls with different BMI index has a reliable value for the early diagnosis of central precocious puberty
and could serve as a practical diagnostic tool for central precocious puberty.
SHI L , JIANG Z Y , ZHANG L . Childhood obesity and central precocious puberty [J ] . Front Endocrinol , 2022 , 13 : 1056871 .
AGUIRRE R S , EUGSTER E A . Central precocious puberty: From genetics to treatment [J ] . Best Pract Res Clin Endocrinol Metab , 2018 , 32 ( 4 ): 343 ‑ 354 .
LATRONICO A C , BRITO V N , CAREL J C . Causes, diagnosis, and treatment of central precocious puberty [J ] . Lancet Diabetes Endocrinol , 2016 , 4 ( 3 ): 265 ‑ 274 .
ZEVIN E L , EUGSTER E A . Central precocious puberty: A review of diagnosis, treatment, and outcomes [J ] . Lancet Child Adolesc Health , 2023 , 7 ( 12 ): 886 ‑ 896 .
MAIONE L , BOUVATTIER C , KAISER U B . Central precocious puberty: Recent advances in understanding the aetiology and in the clinical approach [J ] . Clin Endocrinol , 2021 , 95 ( 4 ): 542 ‑ 555 .
中华医学会儿科学分会内分泌遗传代谢学组 . 中枢性(真性)性早熟诊治指南 [J ] . 中华儿科杂志 , 2007 , 45 ( 6 ): 426 ‑ 427 .
Endocrinology, Genetics and Metabolism Group, Pediatrics Society of Chinese Medical Association . Guidelines for diagnosis and treatment of central (true) precocious puberty [J ] . Chinese Journal of Pediatrics , 2007 , 45 ( 6 ): 426 ‑ 427 .
张亚钦 , 李辉 , 宗心南 , 等 . 中国0~18岁儿童青少年坐高下肢长比和坐高身高比的参照标准与生长曲线 [J ] . 中国循证儿科杂志 , 2023 , 18 ( 4 ): 298 ‑ 302 .
ZHANG Y Q , LI H , ZONG X N , et al . Growth charts of sitting‑height/leg length ratio and sitting‑height/height ratio for Chinese children and adolescents aged 0‑18 years [J ] . Chin J Evid Based Pediatr , 2023 , 18 ( 4 ): 298 ‑ 302 .
FUQUA J S , EUGSTER E A . History of puberty: Normal and precocious [J ] . Horm Res Paediatr , 2022 , 95 ( 6 ): 568 ‑ 578 .
KILBERG M J , VOGIATZI M G . Approach to the patient: Central precocious puberty [J ] . J Clin Endocrinol Metab , 2023 , 108 ( 8 ): 2115 ‑ 2123 .
CHIRICO V , LACQUANITI A , SALPIETRO V , et al . Central precocious puberty: From physiopathological mechanisms to treatment [J ] . J Biol Regul Homeost Agents , 2014 , 28 ( 3 ): 367 ‑ 375 .
BRAMBILLA I , GUARRACINO C , PISTONE C , et al . Role of luteinizing hormone urinary levels in the diagnostic and therapeutic management of female central precocious puberty [J ] . Ital J Pediatr , 2023 , 49 ( 1 ): 100 .
SCHUBERT S , HVELPLUND A H , HANDBERG A , et al . Elevated pre‑injection basal luteinizing hormone concentrations are common in girls treated for central precocious puberty [J ] . J Clin Res Pediatr Endocrinol , 2021 , 13 ( 2 ): 204 ‑ 211 .
王伟 , 曹妞妞 , 肖雅 , 等 . 黄体生成素基础值联合子宫体积对不同Tanner分期女童中枢性性早熟早期诊断价值的研究 [J ] . 中国当代儿科杂志 , 2023 , 25 ( 2 ): 159 ⁃ 165 .
WANG W , CAO N N , XIAO Y , et al . Value of basal luteinizing hormone level combined with uterine volume measurement in the early diagnosis of central precocious puberty in girls with different Tanner stages [J ] . Chin J Contemp Pediatr , 2023 , 25 ( 2 ): 159 ‑ 165 .
CHEN T , ZHANG D B . Basal gonadotropin levels combine with pelvic ultrasound and pituitary volume: A machine learning diagnostic model of idiopathic central precocious puberty [J ] . BMC Pediatr , 2023 , 23 ( 1 ): 603 .
HE J S , KANG Y Y , ZHENG L X . Correlation of serum levels of LH, IGF‑1 and leptin in girls with the development of idiopathic central precocious puberty [J ] . Minerva Pediatr , 2023 , 75 ( 3 ): 381 ‑ 386 .
LIU Y P , CHENG Y Y , SUN M , et al . Analysis of serum insulin‑like growth factor‑1, fibroblast growth factor 23, and Klotho levels in girls with rapidly progressive central precocious puberty [J ] . Eur J Pediatr , 2023 , 182 ( 11 ): 5007 ‑ 5013 .
CHANG H P , YANG S F , WANG S L , et al . Associations among IGF‑1, IGF2, IGF‑1R, IGF‑2R, IGFBP‑3, insulin genetic polymorphisms and central precocious puberty in girls [J ] . BMC Endocr Disord , 2018 , 18 ( 1 ): 66 .
OUYANG L X , YANG F . Combined diagnostic value of insulin‑like growth factor‑1, insulin‑like growth factor binding protein‑3, and baseline luteinizing hormone levels for central precocious puberty in girls [J ] . J Pediatr Endocrinol Metab , 2022 , 35 ( 7 ): 874 ‑ 879 .
TOUTOUDAKI K , PALTOGLOU G , PAPADIMITRIOU D T , et al . The role of SNPs in the pathogenesis of idiopathic central precocious puberty in girls [J ] . Children (Basel) , 2023 , 10 ( 3 ): 450 .
0
浏览量
12
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621